Search

Recent news

People sitting on chairs with their backs to the camera looking at a presentation screen

Amprologix presents at AMR conference in Basel

Mat Upton, CSO, presented new data at the 9th AMR conference in Basel on 25th February. It was suggested that…

Amprologix to attend London’s Investival Showcase

Amprologix will be attending the Investival Showcase in London on 18th November 2024 Amprologix will be attending the Investival Showcase in…

Launch of new patent series for AI-designed molecules

Amprologix files the first of a new series of patents protecting novel molecular structures for the treatment of bacterial infections.…

UKRI Innovate UK Logo

Amprologix secures £1M Innovate UK Biomedical Catalyst award…

Innovate UK has awarded Amprologix £1M of Biomedical Catalyst funding to continue the Tobraderm project 1st March 2024 Amprologix is…

Amprologix selected to pitch at the World Innovation…

October 2022 CSO Mat Upton joined 19 other start-ups that were selected from 700 applicants for a place at the…

News categories

News articles

2 December 2020
Amprologix engages corporate finance partners FRP for its seed and series-A investment rounds

We are delighted to be working with Adrian Gare and Alex Starling at FRP, who have a great track record in early stage financing and bring a wealth of life science sector experience to the team.

Read More
2 December 2020
Amprologix moves into new offices at Plymouth Science Park

Having been based in the Marine Building at Plymouth University for the last 2-years, the company is now moving to the Derriford Research Facility to accommodate our expansion plans as we transition into the clinical phase of our antibiotic discovery programmes.

Read More
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram